Emsculpt and Emsculpt NEO: How It Works, Cost and Results

Emsculpt is the brand name BTL Industries uses for its HIFEM body-contouring devices.

In FDA's records the devices are listed as powered muscle stimulators, and BTL markets Emsculpt as an FDA-cleared treatment.

The first FDA clearance of a BTL HIFEM body device came through the 510(k) pathway on February 16, 2017, for a device listed as the AM-100 (K163165).

An updated model, the BTL 799-2 (K180813), was cleared on June 14, 2018, with wording for improvement of abdominal tone, strengthening of the abdominal muscles and development of a firmer abdomen, and for strengthening, toning and firming of buttocks and thighs.

Two later clearances extended the muscle indications: one covering the arms (October 23, 2018) and one covering the calves (July 5, 2019).

That makes five cleared muscle areas across the family: abdomen, buttocks, thighs, arms and calves.

One caveat belongs next to any clearance claim you read: FDA's 510(k) documents list model numbers, not brand names.

The mapping of the BTL 799 model family to the Emsculpt brand is inferred from BTL being the applicant, the device type and the timing — it is BTL's own marketing that connects the names.

The same applies to the Emsculpt NEO name.

These are clearances, not approvals: the records cited on this page are 510(k) device clearances, which is a different authorization from the FDA approval a prescription drug receives.

None of the FDA records this page cites is an approval — which is why this guide says cleared throughout, never approved.

The difference comes down to two device families with two different sets of cleared uses.

The original Emsculpt-type devices are HIFEM only, and their cleared indications are all about muscle: tone, strength and firmness.

Those clearances do not include a fat-reduction indication.

Emsculpt NEO is the market name for BTL's BTL-899 device family, which combines radiofrequency with HIFEM.

Its first clearance on file (K192224) is dated December 5, 2019, and covers non-invasive lipolysis — the breakdown of fat — and reduction in circumference of the abdomen, originally only for skin types I–III.

Later versions added the thighs (2021) and extended coverage to skin types I–VI (July 2021).

The 2023 clearance (K230467, September 21, 2023) covers: lipolysis and circumference reduction of the abdomen and thighs for skin types I–VI, lipolysis of the flanks limited to skin types I–IV, and lipolysis of the upper arms limited to skin types II–III and BMI 30 or under.

In August 2024, BTL also received a 510(k) for a BTL-899MS device (K240234) under the product code for powered muscle stimulators used in rehabilitation.

Trade press reported this as an Emsculpt NEO clearance for rehabilitative uses such as muscle re-education and preventing disuse atrophy.

We could read the clearance record itself but not its indication wording, so treat the rehabilitation use as reported rather than confirmed.

Emsculpt NEO is not the only fat-reduction device cleared in this space: CoolSculpting is cleared for cold-assisted lipolysis of several body areas at BMI 30 or less, and the area under the chin and jaw at BMI up to 46.2.

The cleared areas differ between the two families, and the NEO fat-reduction clearances carry skin-type and BMI limits that vary by area.

This is what the clearances reviewed for this guide name.

Because the skin-type limits differ by area, no blanket "works for all skin types" statement matches the clearances: the abdomen and thighs are covered across skin types I–VI, the flanks only for skin types I–IV, and the upper arms only for skin types II–III.

BTL markets Emsculpt NEO for patients up to BMI 35.

That is BTL's own eligibility line for the brand, and it is not the same thing as the clearance limits — the cleared upper-arm fat indication stops at BMI 30 and under.

Ask a practice how it applies both numbers to you.

A use that is not in a device's cleared wording is not a cleared use for that device.

If a menu offers Emsculpt for an area or purpose you do not see above, ask the practice what the device is being used for.

BTL says an Emsculpt NEO session lasts 30 minutes and that the typical protocol is four sessions scheduled 5–10 days apart, for patients up to BMI 35.

Those are the manufacturer's described protocol figures.

The 2019 MRI study cited below measured people after four Emsculpt abdominal treatments — the same count as BTL's described Emsculpt NEO protocol, though that study measured the original Emsculpt device.

What we could not confirm in the sources reviewed for this guide is any maintenance schedule — whether, and how often, the series is repeated to keep the measured changes.

If a practice recommends ongoing sessions, ask what that recommendation is based on.

The honest answer first: we could not confirm a national price for Emsculpt or Emsculpt NEO.

No manufacturer list price, and no professional-body or survey figure for these devices, appears in the sources reviewed for this guide, so this page will not quote one.

With no published figure to check a quote against, the price you see is the practice's own.

What we can describe is the pricing structure.

Treatment is counted in sessions — BTL says a typical Emsculpt NEO protocol is four 30-minute sessions — so a quote may be a per-session price, a package price for the series, or both.

Ask each practice for its per-session price and the total for the full protocol, and what happens to payment if you stop after fewer sessions.

For a closer look at quotes and packages, see Emsculpt NEO cost.

What drives the number you are quoted: how many areas are treated, how many sessions are in the plan, the practice's location and pricing structure, and any package, membership or promotional pricing it offers.

If you would pay over time, read the terms before signing: our med spa financing guide compares the pay-over-time programs practices may offer.

A tax note, since body contouring is cosmetic: IRS Publication 502 says cosmetic procedures that only improve appearance, without promoting proper body function or treating disease, are generally not deductible medical expenses — it names hair transplants and liposuction as examples.

Whether any procedure or program qualifies in your case depends on your own circumstances.

Two different kinds of numbers exist for Emsculpt NEO, and they should not be confused: the figures in BTL's marketing, and the measurements in small published studies.

BTL advertises results as 25% muscle growth and 30% fat reduction — asterisked, study-based averages on its own site.

Those are the maker's own figures: the underlying studies are small and mostly BTL-sponsored, and an average across a study is not what any one person gets.

The published studies we could verify are small, single-arm series without a control group.

A 2019 MRI study in Lasers in Surgery and Medicine (22 people, four Emsculpt abdominal treatments) reported an average 18.6% reduction in fat thickness, a 15.4% increase in rectus abdominis muscle thickness and a 10.4% reduction in abdominal separation (diastasis recti) at 2 months, plus an average 3.8 cm reduction in waist circumference.

A 2020 follow-up in Aesthetic Surgery Journal scanned 21 people about 1 year after HIFEM treatment and reported mean reductions versus baseline of 14.6% in fat (2.97 mm in absolute terms) and 10.5% in diastasis, and 19.1% muscle thickening; no adverse events were reported.

The authors themselves write that the durability of the results needs verification.

Read those numbers for what they are: average changes measured in groups of 22 and 21 people, not a prediction for your body and not a promised result.

The verifiable safety record in the sources we reviewed is thin.

The 2020 study of 21 people scanned at about 1-year follow-up reported no adverse events — that is the only adverse-event finding in the studies cited on this page, and 21 people is a small group.

BTL says there is no downtime after Emsculpt NEO.

That is the manufacturer's statement about its own device, not an independent finding, and it is not something this guide can confirm.

That combination — small studies and manufacturer statements — is the honest state of the published evidence we could check.

Before booking, ask the practice what effects its own patients report, what sensations during a session are normal, and when it wants to hear from you about anything that feels wrong afterward.

If you ever have what feels like a medical emergency after a treatment, seek emergency care; for anything else, contact the practice that treated you.

Emsculpt and Emsculpt NEO are brand names, so start with the device itself: ask any practice you are considering which BTL device it runs.

The muscle-only Emsculpt-type family and the radiofrequency-plus-HIFEM NEO family have different cleared uses, and the difference decides what a treatment can honestly be described as.

Second, ask who will operate the device and what license and training they hold.

The sources reviewed for this guide do not establish who may operate an Emsculpt device, so ask the practice directly rather than assuming.

Third, match what you are quoted to the cleared wording above.

If a menu advertises Emsculpt for an area or purpose that is not in the cleared wording, ask what the device is being used for and on what basis.

For the wider questions — the medical director, who treats you, provider training, reviews and price — our guide to choosing a med spa works through them point by point.